208 related articles for article (PubMed ID: 33749913)
21. Combining proteins with n-3 PUFAs (EPA + DHA) and their inflammation pro-resolution mediators for preservation of skeletal muscle mass.
Blaauw R; Calder PC; Martindale RG; Berger MM
Crit Care; 2024 Feb; 28(1):38. PubMed ID: 38302945
[TBL] [Abstract][Full Text] [Related]
22. The Effect of Eicosapentaenoic and Docosahexaenoic Acid Supplementation on Coronary Artery Calcium Progression in Subjects with Diabetes and Coronary Artery Disease: A Secondary Analysis of a Randomized Trial.
Asbeutah AA; Daher R; Malik A; Hariri E; Alfaddagh A; Elajami TK; Welty FK
Am J Cardiol; 2024 Jun; ():. PubMed ID: 38885922
[TBL] [Abstract][Full Text] [Related]
23. Prolonged experimental sleep disturbance affects the inflammatory resolution pathways in healthy humans.
Engert LC; Mullington JM; Haack M
Brain Behav Immun; 2023 Oct; 113():12-20. PubMed ID: 37369338
[TBL] [Abstract][Full Text] [Related]
24. Impact of Resolvin-E1 and Maresin-1 on Bone Marrow Stem Cell Osteogenesis under Inflammatory Stress.
AlZahrani S; Shinwari Z; Alaiya A; Al-Kahtani A
Cells; 2024 May; 13(11):. PubMed ID: 38891064
[TBL] [Abstract][Full Text] [Related]
25. Human macrophages differentially produce specific resolvin or leukotriene signals that depend on bacterial pathogenicity.
Werz O; Gerstmeier J; Libreros S; De la Rosa X; Werner M; Norris PC; Chiang N; Serhan CN
Nat Commun; 2018 Jan; 9(1):59. PubMed ID: 29302056
[TBL] [Abstract][Full Text] [Related]
26. Higher docosahexaenoic acid levels lower the protective impact of eicosapentaenoic acid on long-term major cardiovascular events.
Le VT; Knight S; Watrous JD; Najhawan M; Dao K; McCubrey RO; Bair TL; Horne BD; May HT; Muhlestein JB; Nelson JR; Carlquist JF; Knowlton KU; Jain M; Anderson JL
Front Cardiovasc Med; 2023; 10():1229130. PubMed ID: 37680562
[TBL] [Abstract][Full Text] [Related]
27. Improved arterial inflammation with high dose omega-3 fatty acids in patients with elevated lipoprotein(a): Selective effect of eicosapentaenoic acid?
Ward NC; Ying Q; Chan DC; Pang J; Mori TA; Schultz CJ; Dwivedi G; Francis RJ; Watts GF
J Clin Lipidol; 2023; 17(5):694-699. PubMed ID: 37598001
[TBL] [Abstract][Full Text] [Related]
28. Colorectal ALOX15 as a host factor determinant of EPA and DHA effects on colorectal carcinogenesis.
Zuo X; Kiyasu Y; Liu Y; Deguchi Y; Liu F; Moussalli M; Tan L; Wei B; Wei D; Yang P; Shureiqi I
bioRxiv; 2024 May; ():. PubMed ID: 38746303
[TBL] [Abstract][Full Text] [Related]
29. Resolvin E1 improves efferocytosis and rescues severe aplastic anemia in mice.
Grazda R; Seyfried AN; Maddipati KR; Fredman G; MacNamara KC
Cell Death Dis; 2024 May; 15(5):324. PubMed ID: 38724533
[TBL] [Abstract][Full Text] [Related]
30. Leukotriene B4 levels in human atherosclerotic plaques and abdominal aortic aneurysms.
van den Borne P; van der Laan SW; Bovens SM; Koole D; Kowala MC; Michael LF; Schoneveld AH; van de Weg SM; Velema E; de Vries JP; de Borst GJ; Moll FL; de Kleijn DP; Quax PH; Hoefer IE; Pasterkamp G
PLoS One; 2014; 9(1):e86522. PubMed ID: 24475136
[TBL] [Abstract][Full Text] [Related]
31. Specialized pro-resolution mediators in the bladder: effects of resolvin E1 on diabetic bladder dysfunction in the type 1 diabetic male Akita mouse model.
Cervantes A; Hughes FM; Jin H; Purves JT
BMC Urol; 2024 Jun; 24(1):130. PubMed ID: 38907230
[TBL] [Abstract][Full Text] [Related]
32. Effect of specialized pro-resolving lipid mediators in the regulation of vascular tone and inflammation in human saphenous vein.
Celik Z; Ozen G; Sunar S; Turkyilmaz S; Turkyilmaz G; Kavala AA; Teskin O; Dogan BSU; Topal G
Prostaglandins Other Lipid Mediat; 2023 Dec; 169():106786. PubMed ID: 37806440
[TBL] [Abstract][Full Text] [Related]
33. Resolution of Inflammation in Neurodegenerative Diseases: The Role of Resolvins.
Chamani S; Bianconi V; Tasbandi A; Pirro M; Barreto GE; Jamialahmadi T; Sahebkar A
Mediators Inflamm; 2020; 2020():3267172. PubMed ID: 32308554
[TBL] [Abstract][Full Text] [Related]
34. EPA, DHA, and resolvin effects on cancer risk: The underexplored mechanisms.
Kiyasu Y; Zuo X; Liu Y; Yao JC; Shureiqi I
Prostaglandins Other Lipid Mediat; 2024 May; 174():106854. PubMed ID: 38825147
[TBL] [Abstract][Full Text] [Related]
35. Polyunsaturated Fatty Acid-Derived Lipid Mediators as Potential Biomarkers for Leprosy Among Individuals with Asymptomatic
Silva CAM; Graham BG; Webb K; Islam MN; Harton M; de Mello Marques MA; Marques de Carvalho F; Pinheiro RO; Spencer J; Sarno EN; Batista Pereira GM; Vidal Pessolani MC; Santos de Macedo C; Belisle JT
ACS Infect Dis; 2023 Aug; 9(8):1458-1469. PubMed ID: 37428112
[TBL] [Abstract][Full Text] [Related]
36. Association between Eicosapentaenoic Acid to Arachidonic Acid Ratio and Characteristics of Plaque Rupture.
Sekimoto T; Koba S; Mori H; Arai T; Yamamoto MH; Mizukami T; Matsukawa N; Sakai R; Yokota Y; Sato S; Tanaka H; Masaki R; Oishi Y; Ogura K; Arai K; Nomura K; Sakai K; Tsujita H; Kondo S; Tsukamoto S; Suzuki H; Shinke T
J Atheroscler Thromb; 2023 Nov; 30(11):1687-1702. PubMed ID: 36967129
[TBL] [Abstract][Full Text] [Related]
37. n-3 Polyunsaturated Fatty Acids Modulate LPS-Induced ARDS and the Lung-Brain Axis of Communication in Wild-Type versus Fat-1 Mice Genetically Modified for Leukotriene B4 Receptor 1 or Chemerin Receptor 23 Knockout.
Hernandez J; Schäffer J; Herden C; Pflieger FJ; Reiche S; Körber S; Kitagawa H; Welter J; Michels S; Culmsee C; Bier J; Sommer N; Kang JX; Mayer K; Hecker M; Rummel C
Int J Mol Sci; 2023 Aug; 24(17):. PubMed ID: 37686333
[TBL] [Abstract][Full Text] [Related]
38. Metabolic transformation of fat in obesity determines the inflammation resolving capacity of splenocardiac and cardiorenal networks in heart failure.
Halade GV; Kain V; De La Rosa X; Lindsey ML
Am J Physiol Heart Circ Physiol; 2022 Jun; 322(6):H953-H970. PubMed ID: 35333119
[TBL] [Abstract][Full Text] [Related]
39. Function of Pro-Resolving Lipid Mediator Resolvin E1 in Type 2 Diabetes.
Sima C; Paster B; Van Dyke TE
Crit Rev Immunol; 2018; 38(5):343-365. PubMed ID: 30806214
[TBL] [Abstract][Full Text] [Related]
40. In Vivo Availability of Pro-Resolving Lipid Mediators in Oxazolone Induced Dermal Inflammation in the Mouse.
Homann J; Suo J; Schmidt M; de Bruin N; Scholich K; Geisslinger G; Ferreirós N
PLoS One; 2015; 10(11):e0143141. PubMed ID: 26599340
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
